Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Prepaid Assets of $9.2 million for Q1 2026, up 762.9% year-over-year from $1.1 million in Q1 2025, and up 459.58% quarter-over-quarter from $1.6 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Prepaid Assets history runs 17 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 762.9% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 762.9% YoY), while the FY2025 annual figure was $1.6 million, up 18.53% from the prior year.
- Prepaid Assets for Q1 2026 stood at $9.2 million, up from $1.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $14.8 million in Q2 2022, with the low at $686000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $9.2 million (2023), against an average of $7.4 million.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets tumbled 91.77% in 2025, then soared 762.9% in 2026.
- Tonix Pharmaceuticals Holding's Prepaid Assets stood at $1.3 million in 2022, then surged by 620.08% to $9.2 million in 2023, then sank by 84.84% to $1.4 million in 2024, then gained by 18.53% to $1.6 million in 2025, then jumped by 459.58% to $9.2 million in 2026.
- Business Quant data shows TNXP's Prepaid Assets at $9.2 million in Q1 2026, $1.6 million in Q4 2025, and $8.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.72 Mn |
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Jun 30, 2025 | 686,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 8.34 Mn |
| Mar 31, 2024 | 10.70 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 12.01 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 14.77 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Sep 30, 2021 | 12.11 Mn |